EKSO BIONICS HOLDINGS INC (EKSO) Forecast, Price Target & Analyst Ratings
NASDAQ:EKSO • US2826444000
11.81 USD
-0.9 (-7.08%)
Last: Mar 12, 2026, 08:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EKSO BIONICS HOLDINGS INC (EKSO).
Forecast Snapshot
Consensus Price Target
$9.69
-17.95% Downside
Next Earnings Forecast
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.23
Revenue Estimate4.641M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$9.69
Upside
-17.95%
From current price of $11.81 to mean target of $9.69, Based on 8 analyst forecasts
Low
$9.60
Median
$9.69
High
$9.98
Price Target Revisions
1 Month
0.00%
3 Months
22.58%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for EKSO. The average price target is 9.69 USD. This implies a price decrease of -17.95% is expected in the next year compared to the current price of 11.81.
The average price target has been revised upward by 22.58% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
EKSO was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about EKSO.
In the previous month the buy percentage consensus was at a similar level.
EKSO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-31 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-11-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-29 | Lake Street | Maintains | Buy -> Buy |
| 2025-05-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-04 | Lake Street | Maintains | Buy -> Buy |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-29 | Lake Street | Maintains | Buy -> Buy |
| 2024-10-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-24 | Lake Street | Initiate | Buy |
| 2024-04-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-07-29 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.23
Revenue Estimate4.641M
Revenue Q2Q37.51%
EPS Q2Q86.97%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
46.51%
Next Earnings Summary
EKSO is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 4.64M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.279M 41.59% | 17.925M -1.94% | 12.799M -28.60% | 23.196M 81.23% | 24.888M 7.29% | 31.209M 25.40% | N/A | |
| EBITDA YoY % growth | -13.414M 8.56% | -8.852M 34.01% | -11.573M -30.74% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.112M 2.88% | -10.46M 30.78% | -13.146M -25.68% | -4.068M 69.05% | -2.475M 39.18% | N/A | N/A | |
| Operating Margin | -82.67% | -58.35% | -102.71% | -17.54% | -9.94% | N/A | N/A | |
| EPS YoY % growth | -16.50 -17.52% | -8.55 48.18% | -4.91 42.57% | -0.42 91.48% | -0.06 85.37% | 0.03 150.00% | 1.22 3,900.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 86.97% | -0.15 87.66% | -0.06 88.67% | 0.03 102.30% |
| Revenue Q2Q % growth | 4.641M 37.51% | 4.386M 113.22% | 6.324M 49.61% | 7.854M 150.13% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.734M 46.81% | -1.02M 74.34% | -408K 70.90% | 204K 104.52% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
26.12%
EPS Next 5 Year
22.46%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
27.67%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
EKSO BIONICS HOLDINGS INC / EKSO Forecast FAQ
What do analysts expect the price target to be for EKSO BIONICS HOLDINGS INC (EKSO)?
8 analysts have analysed EKSO and the average price target is 9.69 USD. This implies a price decrease of -17.95% is expected in the next year compared to the current price of 11.81.
What is the next earnings date for EKSO stock?
EKSO BIONICS HOLDINGS INC (EKSO) will report earnings on 2026-05-04.
What are the consensus estimates for EKSO stock next earnings?
The consensus EPS estimate for the next earnings of EKSO BIONICS HOLDINGS INC (EKSO) is -0.23 USD and the consensus revenue estimate is 4.64M USD.
What is the expected long term growth rate for EKSO BIONICS HOLDINGS INC (EKSO)?
The expected long term growth rate for EKSO BIONICS HOLDINGS INC (EKSO) is 27.67%.